Heteroaryl Derivatives As Parp Inhibitors

Abstract: Disclosed are compounds of formula (I) their tautomeric forms stereoisomers and pharmaceutically acceptable salts thereof wherein ring Ar ring B R1 R5 X Y p q r and s are as defined in the specification pharmaceutical compositions including a compound tautomer stereoisomer or salt thereof and methods of treating or preventing diseases or disorders for example cancer that are amenable to treatment or prevention by inhibiting the PARP enzyme of a subject.

Patent Information

Applicants

Inventors

Specification

Documents